Influenza vaccine
VACCINE TYPE
Four major types are available in the U.S.:
- Inactivated influenza vaccine, Trivalent (IIV3)
- Available as a high-dose vaccine.
- Recombinant influenza vaccine, Trivalent (RIV3)
- Live attenuated influenza vaccine, Trivalent (LAIV3)
- mRNA influenza vaccine, Trivalent
- FDA-approved August 2026; not yet incorporated into CDC’s September 2026 interim influenza vaccine guidance.
- All 2026-27 Influenza season vaccines will be trivalent vaccines, as the influenza B/Yamagata lineage is no longer circulating.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 31, 2026
Citation
Dzintars, Kathryn. "Influenza Vaccine." Johns Hopkins HIV Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545284/all/Influenza_vaccine.
Dzintars K. Influenza vaccine. Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545284/all/Influenza_vaccine. Accessed November 9, 2026.
Dzintars, K. (2026). Influenza vaccine. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545284/all/Influenza_vaccine
Dzintars K. Influenza Vaccine [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. [cited 2026 November 09]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545284/all/Influenza_vaccine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Influenza vaccine
ID - 545284
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2026/10/31/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545284/all/Influenza_vaccine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -

Johns Hopkins HIV Guide

